Latest financial market updates and expert analysis
Analysis The iShares MSCI World ETF enters the final stretch of summer with an unusual confluence of tailwinds — some visible in the fund’s price chart, others buried in exchange filings...
The arithmetic at Evotec has rarely looked more contradictory. In the first half of 2026, the company’s core drug discovery...
The Danish pharmaceutical giant is fighting on several fronts at once—and the market can’t seem to agree on whether that’s...
The arithmetic is small — C$10,000 in cancelled subscriptions, a rounding error against a C$1.475 million raise. But the optics...
Investors parsing Bayer’s second-quarter numbers are confronting a company that is simultaneously healing and straining. The German life-science group delivered...
The paperwork is in, the court date is set, and European Lithium shareholders are looking at a payout that will...
There is a peculiar disconnect playing out at Rocket Lab right now. On one side of the ledger sits a...
The distance between a semiconductor startup’s engineering milestones and its income statement is rarely wider than it is at BrainChip...
The market’s reaction on Friday offered a stark reminder of how quickly sentiment can shift in the junior mining space....
The Danish drugmaker is presenting investors with a puzzle: its own treasury desk is hoovering up shares at a record...
The Munich-based buyout firm has just closed the largest acquisition in its history, yet the share price response has been...
